Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Dermatological Therapeutics Market Status and Forecast (2016-2027)
  • 1.3.2 Global Dermatological Therapeutics Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Dermatological Therapeutics Supply by Company

• 2.1 Global Dermatological Therapeutics Sales Value by Company
• 2.2 Dermatological Therapeutics Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Dermatological Therapeutics Market Status by Category

• 3.1 Dermatological Therapeutics Category Introduction
  • 3.1.1 Anti-infectives
  • 3.1.2 Corticosteroids
  • 3.1.3 Anti Psoriasis
  • 3.1.4 Anti-acne
  • 3.1.5 Others
• 3.2 Global Dermatological Therapeutics Market by Category
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Dermatological Therapeutics Market Status by End User/Segment

• 4.1 Dermatological Therapeutics Segment by End User/Segment
  • 4.1.1 Hospital
  • 4.1.2 Clinic
• 4.2 Global Dermatological Therapeutics Market by End User/Segment
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Dermatological Therapeutics Market Status by Region

• 5.1 Global Dermatological Therapeutics Market by Region
• 5.2 North America Dermatological Therapeutics Market Status
• 5.3 Europe Dermatological Therapeutics Market Status
• 5.4 Asia Pacific Dermatological Therapeutics Market Status
• 5.5 Central & South America Dermatological Therapeutics Market Status
• 5.6 Middle East & Africa Dermatological Therapeutics Market Status

6 North America Dermatological Therapeutics Market Status

• 6.1 North America Dermatological Therapeutics Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Dermatological Therapeutics Market Status

• 7.1 Europe Dermatological Therapeutics Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Dermatological Therapeutics Market Status

• 8.1 Asia Pacific Dermatological Therapeutics Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Dermatological Therapeutics Market Status

• 9.1 Central & South America Dermatological Therapeutics Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Dermatological Therapeutics Market Status

• 10.1 Middle East & Africa Dermatological Therapeutics Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Dermatological Therapeutics Market Forecast by Category and by End User/Segment

• 12.1 Global Dermatological Therapeutics Sales Value Forecast (2022-2027)
• 12.2 Global Dermatological Therapeutics Forecast by Category
• 12.3 Global Dermatological Therapeutics Forecast by End User/Segment

13 Global Dermatological Therapeutics Market Forecast by Region/Country

• 13.1 Global Dermatological Therapeutics Market Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Onset Therapeutics
  • 14.1.1 Company Information
  • 14.1.2 Dermatological Therapeutics Product Introduction
  • 14.1.3 Onset Therapeutics Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Medicis
  • 14.2.1 Company Information
  • 14.2.2 Dermatological Therapeutics Product Introduction
  • 14.2.3 Medicis Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Genentech
  • 14.3.1 Company Information
  • 14.3.2 Dermatological Therapeutics Product Introduction
  • 14.3.3 Genentech Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Ferndale
  • 14.4.1 Company Information
  • 14.4.2 Dermatological Therapeutics Product Introduction
  • 14.4.3 Ferndale Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Eisai
  • 14.5.1 Company Information
  • 14.5.2 Dermatological Therapeutics Product Introduction
  • 14.5.3 Eisai Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Dermik
  • 14.6.1 Company Information
  • 14.6.2 Dermatological Therapeutics Product Introduction
  • 14.6.3 Dermik Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Chester Valley
  • 14.7.1 Company Information
  • 14.7.2 Dermatological Therapeutics Product Introduction
  • 14.7.3 Chester Valley Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Amgen
  • 14.8.1 Company Information
  • 14.8.2 Dermatological Therapeutics Product Introduction
  • 14.8.3 Amgen Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Allergan
  • 14.9.1 Company Information
  • 14.9.2 Dermatological Therapeutics Product Introduction
  • 14.9.3 Allergan Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 AGI Dermatics
  • 14.10.1 Company Information
  • 14.10.2 Dermatological Therapeutics Product Introduction
  • 14.10.3 AGI Dermatics Dermatological Therapeutics Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.10.4 SWOT Analysis

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Dermatological Therapeutics market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Dermatological Therapeutics market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Anti-infectives
Corticosteroids
Anti Psoriasis
Anti-acne
Others

Segmented by End User/Segment
Hospital
Clinic

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Onset Therapeutics
Medicis
Genentech
Ferndale
Eisai
Dermik
Chester Valley
Amgen
Allergan
AGI Dermatics